M4MM
MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments
NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a move that underscores its push into late-stage testing ...
Sunderstorm Welcomes Lime to Its Family of Brands
LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the popular Kanha edibles line, revealed its purchase of Lime, an expert in pre-rolled joints that has carved out a steady presence in the state's retail ...
Curaleaf Observes Delaware Base to Tighten U.S. Footprint
DOVER – Curaleaf Holdings Inc. has filed for shareholder approval to relocate its corporate domicile from British Columbia, Canada, to Delaware, a change designed to match its heavy concentration of business in the American market. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments
NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a move that underscores its push into late-stage testing ...
Sunderstorm Welcomes Lime to Its Family of Brands
LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the popular Kanha edibles line, revealed its purchase of Lime, an expert in pre-rolled joints that has carved out a steady presence in the state's retail ...
Curaleaf Observes Delaware Base to Tighten U.S. Footprint
DOVER – Curaleaf Holdings Inc. has filed for shareholder approval to relocate its corporate domicile from British Columbia, Canada, to Delaware, a change designed to match its heavy concentration of business in the American market. ...
Arizona to Launch Recreational Cannabis Home Delivery
LOS ANGELES- Starting November 2024, Arizona will permit home delivery for recreational cannabis, marking a significant shift in state policy. The Arizona Department of Health Services has approved this expansion, previously limited to medical cannabis ...
Cannabis Means Business — a Bold New Vision for CWCBExpo
NEW YORK (New York)-- Cannabis Means Business (CMB) is a new vision for the show previously run as CWCBExpo. This evolution is a significant shift in the landscape of cannabis industry events and reflects the ...
AICPA Calls for IRS Guidance on Cannabis Tax Policy Amid Potential Rescheduling
LOS ANGELES- The American Institute of Certified Public Accountants (AICPA) is calling on the IRS and Treasury Department to provide updated guidance on tax policy for cannabis businesses in light of a potential rescheduling of ...
Green Dragon and Eaze to Close Operations Amid Financial Challenges and Industry Downturn
LOS ANGELES- Green Dragon, a multi-state cannabis operator with facilities in Colorado and Florida, is set to cease operations by the end of 2024. This move will affect all 17 of its dispensaries in Colorado ...
NCIA Among Speakers Approved for DEA’s Landmark Cannabis Rescheduling Hearing in December
LOS ANGELES-The Drug Enforcement Administration (DEA) is preparing for its cannabis rescheduling hearing set for December 2 by selecting speakers to participate. Several organizations, including the National Cannabis Industry Association (NCIA), have received approval to ...
U.S. Cannabis Market Growth Reaches $50 Billion as Industry Grapples with Worker Unionization Efforts
LOS ANGELES- The U.S. cannabis market is on track for substantial growth, with projections indicating retail sales could exceed $50 billion annually within the next several years. In 2023, combined medical and recreational cannabis sales ...
New Report Highlights Key Insights and Challenges in U.S. Alzheimer’s Patient Experience
LOS ANGELES- A new report from ResearchAndMarkets.com, "Alzheimer's Disease in the United States: Understanding the Alzheimer's Patient Experience," provides a data-driven view of the experiences of nearly 7 million Americans living with Alzheimer's. The report, ...
Did You Know… Cannabis Was Once a Legal Cross-Border Import?
LOS ANGELES- A hundred years ago, the U.S. government held a different view on cannabis, or Cannabis sativa L. Known then as “marihuana,” it was also called hemp, Mary Jane, and Mary Warner, among other names. ...
Trulieve Throws the Kitchen Sink at Adult-Use Cannabis in Florida
MIAMI — (HCN) As Florida’s November 5th election approaches, Trulieve, a dominant force in the state’s medical cannabis market, is making an unprecedented push to legalize adult-use cannabis. With a jaw-dropping $141 million contribution to ...
Industrial Hemp Market Poised for Growth, Projected to Reach $25 Billion by 2032
LOS ANGELES-The industrial hemp market is projected to grow substantially, with a forecasted compound annual growth rate (CAGR) of 17.29% through 2032, reaching an estimated value of $25.33 billion. This growth is primarily driven by ...
Massachusetts Ballot to Decide on Psychedelics Legalization in November
LOS ANGELES- Massachusetts voters are set to decide on a significant measure this November with Question 4, a ballot initiative to legalize certain plant-based psychedelics, including psilocybin, mescaline, and dimethyltryptamine (DMT). If approved, Massachusetts would ...
France: The Investment Landscape of the Medical Cannabis Sector
PARIS — Encouraged by the advances of Germany, the investment climate in France's medical cannabis industry is evolving on a promising trajectory, marked by a transition from a history of strict prohibition and stigma to ...
Cannabis Opportunities in Germany: Positive Outlook for Investment and Innovation
BERLIN — The investment climate in Germany's cannabis market is poised for significant expansion, driven by the global cannabis legalization movement, ongoing regulatory changes, and mounting community and market demand. As the country embraces a ...
European Cannabis Update: Embracing the Growing Dutch Medical Cannabis Market
EUROPE — As a pioneer in the recognition and regulation of the medical use of cannabis, the Netherlands has emerged as a prominent hub for cannabis investment, driven by a combination of progressive policies, established ...
Shared Liability in Cannabis: A Smarter Approach to Managing Employee Compliance with Paylient
LOS ANGELES — As the cannabis industry continues to grow, so do the challenges that come with managing employees within a highly regulated environment. From payroll and benefits to labor compliance and HR management, cannabis ...
